Hexal-lisinopril
Every registration of this product has been cancelled.
(2S)-1-[(2S)-6-Amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 5362119.
Registration
- Applicants
- 2
- Registrations
- 3
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Hexal Pharma (SA) (Pty) LtdCancelled | Hexal-lisinopril | 5, 10 | 350225, 350226 | Not determined | None |
| Sandoz South Africa (Pty) LtdCancelled | Hexal-lisinopril | 20 | 350227 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Hexal-lisinopril 5 EACH TABLET CONTAINS LISINOPRIL 5,0 mg | 5 | 35022535/7.1.3/0225 | Cancelled | Not determined | None |
| Hexal-lisinopril 10 EACH TABLET CONTAINS LISINOPRIL 10,0 mg | 10 | 35022635/7.1.3/0226 | Cancelled | Not determined | None |
| Hexal-lisinopril 20 EACH TABLET CONTAINS LISINOPRIL 20,0 mg | 20 | 35022735/7.1.3/0227 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Hydrochlorothiazide
Consolidated Schedules 06 July 2026, line 3721
S3: Lisinopril
Consolidated Schedules 06 July 2026, line 3902
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.